ScoreWhy is Norris Medicines Ltd ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -7.83% and Operating profit at 0% over the last 5 years
- The company has a negative book value of Rs 14.86 crore
2
Risky - Negative Book Value
- The company has a negative book value of Rs. -14.86 cr
- Over the past year, while the stock has generated a return of -29.08%, its profits have risen by 77.4%
- The stock is trading risky as compared to its average historical valuations
3
Below par performance in long term as well as near term
- Along with generating -29.08% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Trading & Distributors)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Norris Medicines for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Norris Medicines
-29.08%
-0.45
65.27%
Sensex
-10.21%
-0.78
13.06%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-7.83%
EBIT Growth (5y)
15.76%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.45
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
-10.03%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
-0.94
EV to EBIT
35.54
EV to EBITDA
35.54
EV to Capital Employed
5.32
EV to Sales
4.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-12.13%
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
PAT(Latest six months)
Higher at Rs 0.75 cr
NET SALES(9M)
Higher at Rs 6.68 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Norris Medicines
Profit After Tax (PAT) - Latest six months
Higher at Rs 0.75 cr
than preceding 12 month period ended Mar 2026 of Rs -1.54 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Net Sales - Nine Monthly
At Rs 6.68 cr has Grown at 30.98%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Nine Monthly
Higher at Rs 6.68 cr
than preceding 12 month period ended Mar 2026 of Rs 6.56 crMOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Sales (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
